Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 220-223

  Jung, Klaus ^a   Nowak, Lars ^a   Lein, Michael ^a   Priem, Friedrich ^a   Schnorr, Dietmar ^a   Loening, Stefan A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

EID: 0031010461     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<220::AID-IJC14>3.0.CO;2-H     Document Type: Article

References (22)

1. ANDERSON, I.C., SUGARBAKER, D.J., GANJU, R.K., TSARWHAS, D.G., RICHARDS, W.G., SUNDAY, M., KOBZIK, L. and SHIPP, M.A., Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary tibroblasts. Cancer Res., 55, 4120-4126 (1995).
2. BAKER, T., TICKLE, S., WASAN, H., DOCHERTY, A., ISENBERG, D. and WAXMAN, J., Serum metalloproteinases and their inhibitors: markers for malignant potential. Brit. J. Cancer, 70, 506-512 (1994).
3. BOAG, A.H. and YOUNG, I.D., Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. Mod. Pathol., 6, 65-68 (1993).
4. BRAMHALL, S.R., STAMP, G.W., DUNN, J., LEMOINE, N.R. and NEOPTOLEMOS, J.P., Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Brit., J. Cancer, 73, 972-978 (1996).
5. CHUA, C.C. and CHUA, B.H., Tumor necrosis factor-alpha induces mRNA for collagenase and TIMP in human skin fibroblasts. Connect. Tissue Res., 25, 161-170 (1990).
6. CRAWFORD, H.C. and MATRISIAN, L.M., Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis, 14, 234-245 (1995).
7. HAMDY, F.C., FADLON, E.J., COTTAM, D., LAWRY, J., THURRELL, W., SILCOCKS, P.B., ANDERSON, J.B., WILLIAMS, J.L. and REES, R.C., Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Brit. J. Cancer, 69, 177-182 (1994).
8. HAYAKAWA, T., YAMASHITA, K., TANZAWA, K., UCHIJIMA, E. and IWATA, K., Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide ranne of cells. A possible new growth factor in serum. FEBS Lett., 298, 29-32 (1992).
9. JUNG, K., NOWAK, L., LEIN, M., HENKE, W., SCHNORR, D. and LOENING, S.A., Role of specimen collection in preanalytical variation of metalloproteinases and their inhibitors. Clin. Chem., 42, 2043-2045 (1996).
10. KAKEHI, Y., OKA, H., MITSUMORI, K., OGAWA, O. and YOSHIDA, O., Serum TGF-β1 levels in patients with prostatic cancer: positive correlation with metastasis and inverse correlation w ith age. J. Urol., 155, 419A (1996).
11. KNOX, J.D., WOLF, C., MCDANIEL, K., CLARK, V., LORIOT, M., BOWDEN, G.T. and NAGLE, R.B., Matrilysin expression in human prostate carcinoma. Mol. Carcinogenesis, 15, 57-63 (1996).
12. LI, J., ROSMAN, A.S., LEO, M.A., NAGAI, Y. and LIEBER, C.S., Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology, 19, 1418-1423 (1994).
13. LIOTTA, L.A. and STETLER-STEVENSON, W.G., Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res., 51, 5054s-5059s (1991).
14. MANICOURT, D.H., FUJIMOTO, N., OBATA, K. and THONAR, E.J., Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation. Arthritis Rheum., 38, 1031-1039 (1995).
15. MURRAY, G.I., DUNCAN, M.E., O'NEIL, P., MELVIN, W.T. and FOTHERGILL, J.E., Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature (Med), 2, 461-462 (1996).
16. NAKATSUKASA, H. and 13 OTHERS, Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human cellular carcinomas. Hepatology, 24, 82-88 (1996).
17. PAJOUH, M.S., NAGLE, R.B., BREATHNACH, R., FINCH, J.S., BRAWER, M.K. and BOWDEN, G.T., Expression of metalloproteinase genes in human prostate cancer. J. Cancer Res. clin. Oncol., 117, 144-150 (1991).
18. SOLBERG, H.E., Approved recommendations (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determinations of reference limits. J. clin. Chem. clin. Biochem., 25, 645-656 (1987).
19. STEARNS, M. and STEARNS, M.E., Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. Oncol. Res., 8, 69-75 (1996).
20. 2 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53, 878-883 (1993).
21. ZENG, Z.S., COHEN, A.M., ZHANG, Z.F., STETLER-STEVENSON, W.G. and GUILLEM, J.G., Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin. Cancer Res., 1, 899-906 (1995).
22. ZUCKER, S., LYSIK, R.M., DIMASSIMO, B.I., ZARRABI, H.M., MOLL, U.M., GRIMSOM, R., TICKLE, S.P. and DOCHERTY, A.J., Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer. Cancer, 76, 700-708 (1995).